Stay updated with breaking news from Vitro Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Surmodics (NASDAQ:SRDX – Free Report) had its price objective lowered by Needham & Company LLC from $47.00 to $43.00 in a report released on Wednesday morning, Benzinga reports. The brokerage currently has a buy rating on the stock. Separately, StockNews.com downgraded Surmodics from a strong-buy rating to a buy rating in a report on Wednesday, […]
Surmodics (NASDAQ:SRDX – Get Free Report) announced its earnings results on Wednesday. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.36) by $0.43, Zacks reports. The business had revenue of $31.96 million during the quarter, compared to analyst estimates of $28.79 million. Surmodics had a net margin […]
CONFIDENTIAL AND PROPRIETARY - © Eurofins Scientific Ltd, 2024. All rights reserved. This document contains information that is confidential and proprietary to Eurofins Scientific SE...
Regulatory News: The Eurofins network of companies continues to deliver resilient growth: Reported revenues in Q1 2024 totalled €1,653m, an increase of 5.0% vs Q1 2023, driven by solid...
StockNews.com upgraded shares of Surmodics (NASDAQ:SRDX – Free Report) from a buy rating to a strong-buy rating in a research report sent to investors on Tuesday. Separately, Needham & Company LLC reissued a buy rating and set a $47.00 target price on shares of Surmodics in a research report on Wednesday, April 10th. View Our […]